Literature DB >> 16831743

Are the metabolic alterations associated with critical illness related to the hormonal environment?

D W Wilmore1.   

Abstract

The hormonal environment has a direct effect on mediating the catabolic response to critical illness. Administering hormones to normal volunteers simulated many, but not all, of the alterations observed in patients following injury or severe injection. The administration of an inflammatory agent, etiocholanolone, initiated a variety of acute phase responses and interacted with hormonally mediated changes to elicit a variety of responses commonly observed in critically ill patients. Further studies have manipulated the hormone environment in critically ill patients by administering anabolic factors or blocking catabolic hormone elaboration. These investigations have demonstrated a marked attenuation of many of the catabolic responses to critical illness. Such manipulations give some insight into the potential for patient care in the future, where catabolic responses could be successfully blunted, and anabolic hormones administered so as to prevent the marked wasting and tissue disruption that heretofore have commonly been associated with catabolic disorders.

Entities:  

Year:  1986        PMID: 16831743     DOI: 10.1016/0261-5614(86)90037-3

Source DB:  PubMed          Journal:  Clin Nutr        ISSN: 0261-5614            Impact factor:   7.324


  3 in total

1.  Nutrition in respiratory failure.

Authors:  G Iapichino
Journal:  Intensive Care Med       Date:  1989       Impact factor: 17.440

2.  Effects of indomethacin on endocrine responses and nitrogen loss after surgery.

Authors:  T Asoh; C Shirasaka; I Uchida; H Tsuji
Journal:  Ann Surg       Date:  1987-12       Impact factor: 12.969

3.  Urinary Metabolomics Identifies a Molecular Correlate of Interstitial Cystitis/Bladder Pain Syndrome in a Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research Network Cohort.

Authors:  Kaveri S Parker; Jan R Crowley; Alisa J Stephens-Shields; Adrie van Bokhoven; M Scott Lucia; H Henry Lai; Gerald L Andriole; Thomas M Hooton; Chris Mullins; Jeffrey P Henderson
Journal:  EBioMedicine       Date:  2016-03-31       Impact factor: 8.143

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.